Connecticut 2019 Regular Session

Connecticut House Bill HB05851

Introduced
1/23/19  
Introduced
1/23/19  
Refer
1/23/19  

Caption

An Act Concerning The Application Of Cost-sharing Assistance Payments For Covered Prescription Drugs.

Impact

If the bill passes, it will significantly impact the financial dynamics of health insurance coverage in the state. Patients who currently struggle with out-of-pocket expenses for prescription drugs could benefit from reduced cost-sharing obligations, as their cost-sharing assistance payments would be deducted from their overall financial responsibilities. This bill seeks to improve access to necessary medications by making them more affordable for insured individuals, potentially enhancing health outcomes over time.

Summary

House Bill 05851 is designed to amend Title 38a of the general statutes concerning health insurance policies and their application of cost-sharing assistance payments for prescription drugs. Specifically, the bill mandates that all insurers and health service entities operating in the state apply any cost-sharing assistance payments received by insured individuals from pharmaceutical manufacturers directly to the insured's cost-sharing obligations when it comes to covered prescription drugs. The intention behind this legislation is to alleviate some of the financial burdens faced by patients requiring medication.

Contention

The conversations surrounding HB 05851 may include points of contention regarding the financial implications for both insurance providers and pharmaceutical companies. While proponents argue that it enhances patient support and affordability, opponents may raise concerns about the potential increase in costs for health care providers, as they may have to adjust their pricing models to accommodate the requirement of applying assistance payments. Furthermore, there may be debates about the overall effectiveness of cost-sharing assistance programs in truly making medications accessible and whether this bill adequately addresses the root issues of high prescription drug costs.

Companion Bills

No companion bills found.

Previously Filed As

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

CT SB00182

An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.

CT SB00008

An Act Concerning Drug Affordability.

CT SB00320

An Act Concerning Early Childhood Developmental Disorders.

CT SB00001

An Act Concerning The Health And Safety Of Connecticut Residents.

CT SB00395

An Act Concerning The Reporting Of Medical Debt.

CT HB05247

An Act Concerning Employee Health Benefit Consortiums.

CT HB05503

An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.

CT SB00400

An Act Concerning The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes.

CT SB00180

An Act Concerning Adverse Determination And Utilization Reviews.

Similar Bills

No similar bills found.